|
Glioblastoma |
|
|
|
Susan E. Jones-Bolin, Hugh
Zhao, Kathryn Hunter, Bruce Ruggeri
Effects of chronic oral administration
of the pan VEGF-R kinase inhibitor, CEP-7055, alone and in
combination with temozolomide (TMZ), on primary tumor growth,
neurological dysfunction, and survival in an orthotopic model of
human glioblastoma in nude mice
Proceedings of the AACR, Volume 44, 2nd ed., July 2003, Abstract
No. 61
|
|
|
Gliomas |
|
|
|
|
Qi-Wen Fan,
Zachary A. Knight, David
D. Goldenberg, Wei Yu,
Keith E. Mostov, David Stokoe,
Kevan M. Shokat, and
William
A. Weiss
A dual PI3 kinase/mTOR inhibitor reveals emergent
efficacy in glioma
Cancer Cell 9, 341–349, May
2006. DOI 10.1016/j.ccr.2006.03.029
Abstract
| 
Full
Text | 
Reprint
| Supplemental
Data | 
News
News
|
|
Goldbrunner RH, Bendszus M, Wood J,
Kiderlen M, Sasaki M, Tonn JC
PTK787/ZK222584, an Inhibitor
of Vascular Endothelial Growth Factor Receptor Tyrosine Kinases,
Decreases Glioma Growth and Vascularization
Neurosurgery. 2004 Aug;55(2):426-32
|
|
Sandstrom M, Johansson M, Andersson U,
Bergh A, Bergenheim AT, Henriksson R
The tyrosine kinase inhibitor
ZD6474 inhibits tumour growth in an intracerebral rat glioma
model
Br J Cancer. 2004 Aug 10 [Epub ahead of print]
|
|
|
|
